Andreas Draube

Early Prediction of Nonprogression in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib By Using [¹⁸F]Fluorodeoxyglucose and [¹⁸F]Fluorothymidine Positron Emission Tomography

Thomas Zander, Matthias Scheffler, Lucia Nogová et al. · Journal of Clinical Oncology · 2011 · 172 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo

Elke Pogge von Strandmann, Hinrich P. Hansen, Katrin S. Reiners et al. · Blood · 2005 · 139 citations

Life Sciences, Immunology, Oncology +17

Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab

Jens M. Chemnitz, Andreas Draube, Christof Scheid et al. · American Journal of Hematology · 2002 · 127 citations · Full text

Life Sciences, Hematology, Immunology +16

Constitutive Expression of c-FLIP in Hodgkin and Reed-Sternberg Cells

Roman K. Thomas, Anne Kallenborn, Claudia Wickenhauser et al. · American Journal Of Pathology · 2002 · 117 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +5

Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients

Sebastian Michels, Andreas H. Scheel, Matthias Scheffler et al. · Journal of Thoracic Oncology · 2016 · 98 citations · Full text

Medicine, Cancer Biology, Oncology +11